Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Functional and structural changes in the visual pathway in multiple sclerosis.
Carcelén-Gadea M, Quintanilla-Bordás C, Gracia-García A, García-Villanueva C, Jannone-Pedro N, Álvarez-Sánchez L, Vilaplana-Domínguez L, Blanco-Hernández T, Pons-Amate JM, Cervelló-Donderis A. Carcelén-Gadea M, et al. Brain Behav. 2019 Dec;9(12):e01467. doi: 10.1002/brb3.1467. Epub 2019 Nov 16. Brain Behav. 2019. PMID: 31733096 Free PMC article.
[Involvement of cocaine in cerebral vascular pathology].
Carcelén-Gadea ME, Pons-Amate JM, Climent-Díaz B, García-Escrivá D, Guillén-Fort C. Carcelén-Gadea ME, et al. Rev Neurol. 2012 Jun 1;54(11):664-72. Rev Neurol. 2012. PMID: 22627747 Free article. Spanish.
Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain.
Landete L, Pérez-Miralles F, García S, Belenguer A, Gascón F, Domínguez JA, Carcelén-Gadea M, Quintanilla-Bordás C, Navarro L, Gabaldón L, Casanova B. Landete L, et al. Among authors: carcelen gadea m. Front Neurol. 2021 Oct 29;12:727586. doi: 10.3389/fneur.2021.727586. eCollection 2021. Front Neurol. 2021. PMID: 34803877 Free PMC article.
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.
Alcalá C, Quintanilla-Bordás C, Gascón F, Sempere ÁP, Navarro L, Carcelén-Gadea M, Landete L, Mallada J, Cañizares E, Belenguer A, Carratalá S, Domínguez JA, Pérez-Miralles FC, Gil-Perotín S, Gasqué R, Cubas L, Castillo J, Casanova B. Alcalá C, et al. Among authors: carcelen gadea m. J Neurol. 2022 Jul;269(7):3676-3681. doi: 10.1007/s00415-022-10989-0. Epub 2022 Feb 2. J Neurol. 2022. PMID: 35107597
Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis.
Alcalá Vicente C, Lacruz L, Gascón F, Carratalà S, Quintanilla-Bordás C, Sanz MT, Carcelén-Gadea M, Mallada J, Carreres J, Gabaldón Torres L, Dominguez JA, Cañizares E, Gil-Perotin S, Cubas L, Gasqué Rubio R, Castillo-Villalba J, Pérez-Miralles FC, Casanova B. Alcalá Vicente C, et al. Among authors: carcelen gadea m. Front Neurol. 2022 Oct 28;13:991596. doi: 10.3389/fneur.2022.991596. eCollection 2022. Front Neurol. 2022. PMID: 36388220 Free PMC article.
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
Casanova B, Jarque I, Gascón F, Hernández-Boluda JC, Pérez-Miralles F, de la Rubia J, Alcalá C, Sanz J, Mallada J, Cervelló A, Navarré A, Carcelén-Gadea M, Boscá I, Gil-Perotin S, Solano C, Sanz MA, Coret F. Casanova B, et al. Among authors: carcelen gadea m. Neurol Sci. 2017 Jul;38(7):1213-1221. doi: 10.1007/s10072-017-2933-6. Epub 2017 Apr 10. Neurol Sci. 2017. PMID: 28396953 Free PMC article.
Workplace difficulties, health-related quality of life, and perception of stigma from the perspective of patients with Multiple Sclerosis.
Maurino J, Martínez-Ginés ML, García-Domínguez JM, Solar MD, Carcelén-Gadea M, Ares-Luque A, Ballabriga J, Navarro-Cantó L, Medrano N, Honan CA; W-IMPACT Study Group. Maurino J, et al. Among authors: carcelen gadea m. Mult Scler Relat Disord. 2020 Jun;41:102046. doi: 10.1016/j.msard.2020.102046. Epub 2020 Mar 7. Mult Scler Relat Disord. 2020. PMID: 32179482
Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-β to Glatiramer Acetate in Clinical Practice.
Meca-Lallana J, Hernández L, Caminero AB, Girón JM, Cano-Orgaz A, Carcelén-Gadea M, Muñoz D, Durán-Ferreras E, Martín-Hernández J, Sánchez-de la Rosa R; FATIGA Study Group. Meca-Lallana J, et al. Among authors: carcelen gadea m. Eur Neurol. 2016;76(1-2):40-7. doi: 10.1159/000447630. Epub 2016 Jul 1. Eur Neurol. 2016. PMID: 27376845
11 results